Identification of genes potentially involved in LMO2-induced leukemogenesis

被引:7
作者
Davenport, J
Neale, GAM
Goorha, R
机构
[1] St Jude Childrens Res Hosp, Dept Virol & Mol Biol, Memphis, TN 38105 USA
[2] Univ Tennessee, Coll Med, Dept Pathol & Lab Med, Memphis, TN USA
关键词
LMO-2; T cell leukemias; RDA (representational difference analysis); neuropilin; cyclin d2; hsc73; IA-2; Bub1; TRAP; 230;
D O I
10.1038/sj.leu.2401913
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The most common translocations in childhood T cell acute lymphoblastic leukemias involve the LMO2 locus on chromosome 11p13 and cause ectopic expression of the LMO2 gene in thymocytes. Transgenic mice with enforced expression of LMO2 in their thymocytes develop T cell leukemias thus demonstrating the role of LMO2 in leukemogenesis. The physiologic and leukemogenic functions of LMO2 are mediated through its transcriptional regulatory activities, but the identity of the target genes is completely unknown. In this report, we have used cDNA representational difference analysis (cDNA-RDA) to identify genes that are over-expressed and are likely to play a role in the LMO2 induced leukemias. cDNA-RDA was performed using very small amounts of mRNA pool (from 1 mug of total RNA) to reverse transcribe the cDNAs from leukemic cells or normal thymocytes. The cDNA-RDA led to the isolation of nine distinct clones that were specifically overexpressed in the leukemic cells. Sequence analysis revealed that five of the nine clones had identity or homology to known genes that are known to play a role in the pathogenesis of leukemias or other cancers. Three clones had no significant homology to any known genes and thus represent novel candidate genes. Our study demonstrates that cDNA-RDA using very small amounts of total RNA is a highly efficient method to identify novel genes that may play a role in leukemogenesis.
引用
收藏
页码:1986 / 1996
页数:11
相关论文
共 48 条
[1]   A CLUSTER OF CHROMOSOME-11P13 TRANSLOCATIONS FOUND VIA DISTINCT D-D AND D-D-J REARRANGEMENTS OF THE HUMAN T-CELL RECEPTOR-DELTA CHAIN GENE [J].
BOEHM, T ;
BULUWELA, L ;
WILLIAMS, D ;
WHITE, L ;
RABBITTS, TH .
EMBO JOURNAL, 1988, 7 (07) :2011-2017
[2]  
BRAUN BS, 1995, MOL CELL BIOL, V15, P4623
[3]  
BROWN T, 1995, CURRENT PROTOCOLS MO
[4]   Mutations of mitotic checkpoint genes in human cancers [J].
Cahill, DP ;
Lengauer, C ;
Yu, J ;
Riggins, GJ ;
Willson, JKV ;
Markowitz, SD ;
Kinzler, KW ;
Vogelstein, B .
NATURE, 1998, 392 (6673) :300-303
[5]   DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE-LEUKEMIA - METHODOLOGIC ADVANCES AND CLINICAL-SIGNIFICANCE [J].
CAMPANA, D ;
PUI, CH .
BLOOD, 1995, 85 (06) :1416-1434
[6]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[7]  
Condorelli GL, 1996, CANCER RES, V56, P5113
[8]   ALTERATIONS IN RECEPTOR-MEDIATED KINASES AND PHOSPHATASES DURING CARCINOGENESIS [J].
CREAN, DH ;
LIEBOW, C ;
LEE, MT ;
KAMER, AR ;
SCHALLY, AV ;
MANG, TS .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1995, 121 (03) :141-149
[9]   The mouse mitotic checkpoint gene Bub1b, a novel Bub1 family member, is expressed in a cell cycle-dependent manner [J].
Davenport, JW ;
Fernandes, ER ;
Harris, LD ;
Neale, GAM ;
Goorha, R .
GENOMICS, 1999, 55 (01) :113-117
[10]  
HANNA Z, 1993, ONCOGENE, V8, P1661